Retatrutide Shows Cardiovascular Benefits in Obesity and Type 2 Diabetes | Retatrutide News

Retatrutide is linked to improved cardiovascular risk biomarkers in adults with obesity and type 2 diabetes. This finding supports its potential role in...
Clinical Trials · October 9, 2026